How to appeal a Point32Health continuous glucose monitors & insulin pumps denial
ACA §2719 + ERISA §503 · 180-day window · 30-day decision
The framework that applies to your appeal
Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.
Point32Health-specific note: Formed by 2021 merger of Tufts Health Plan and Harvard Pilgrim Health Care; ~2M members across New England. Brands operate separately (Harvard Pilgrim, Tufts Health Plan). MA DOI primary regulator; MA OPP external review applies in Massachusetts.
What Point32Health typically denies for continuous glucose monitors & insulin pumps
Across Point32Health's commercial and Medicare books, denials cluster around a small number of patterns. For continuous glucose monitors & insulin pumps, expect:
- Harvard Pilgrim vs Tufts Health Plan operational differences (pre-merger legacy)
- MA mandated benefit disputes
- Specialty drug PA
- Behavioral health prior auth
Treatments most often denied in this category
These are the continuous glucose monitors & insulin pumps treatments most often flagged for prior auth, step therapy, or medical necessity review:
- Dexcom G7
- Dexcom G6
- Libre 3 Plus
- Libre 2 Plus
- Eversense 365
- Tandem t:slim X2
How to submit the appeal to Point32Health
- Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
- Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Point32Health cited in the denial.
- File the appeal through Point32Health's portal (members: https://www.point32health.org ; providers: https://www.point32health.org/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
- If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MA, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.
Frequently asked questions
How long do I have to appeal a Point32Health continuous glucose monitors & insulin pumps denial?
Point32Health allows 180 days from the date on the denial letter to file an internal appeal. Standard decisions come back within 30 days; expedited decisions for urgent care typically within 72 hours.
What's the fastest way to submit a Point32Health appeal?
Members can submit through the Point32Health member portal at https://www.point32health.org. Providers should use the provider portal at https://www.point32health.org/providers. Faxed and mailed appeals are accepted but take longer.
What denials does Point32Health most often issue for continuous glucose monitors & insulin pumps?
Across Point32Health's book of business the common patterns include: Harvard Pilgrim vs Tufts Health Plan operational differences (pre-merger legacy); MA mandated benefit disputes; Specialty drug PA. For continuous glucose monitors & insulin pumps specifically, expect denials tied to the FDA-approved indication, step therapy through cheaper alternatives, and prior authorization documentation gaps.
What if Point32Health denies the appeal too?
After an internal appeal denial you have the right to an external review by an independent reviewer (IRO) — request it within 4 months of the final internal denial.
Start your Continuous glucose monitors & insulin pumps appeal
Upload your Point32Health denial letter — DenialHelp drafts a physician-ready appeal in five minutes, aligned to ACA §2719 + ERISA §503.
Get started →Contact: hello@denialhelp.com